PUBLISHER: Grand View Research | PRODUCT CODE: 1813841
PUBLISHER: Grand View Research | PRODUCT CODE: 1813841
The U.S. orthopedic contract manufacturing market size was estimated at USD 2.48 billion in 2024 and is projected to reach USD 7.28 billion by 2033, growing at a CAGR of 13.16% from 2025 to 2033. The market growth is driven by increased procedural volumes related to joint reconstruction, trauma, and spine surgeries. Besides, growth is further supported by rising original equipment manufacturers (OEMs) outsourcing operations to enhance efficiency and shorten time-to-market.
In addition, the rising aging population and a growing sports injuries have contributed to the increased demand for orthopedic implants and surgical instruments. Moreover, the cost pressures have led OEMs to depend on contract manufacturers for precision machining, cleanroom assembly, and regulatory support, fueling the long-term collaborations throughout the supply chain. Besides, technological innovations have notably impacted implant design, instrumentation, and sterilization methods. 3D printing has gained momentum, particularly for creating patient-specific implants and tools. High-performance materials like PEEK, titanium alloys, and bioresorbables are increasingly being utilized.
U.S. orthopedic contract manufacturing market size and growth forecast (2023-2033)
The integration of digital manufacturing tools, automation, and AI-driven quality control systems into production processes has increased. There has also been exploration into innovative surgical instruments and IoT-enabled trays for better hospital inventory management and procedural planning. Substantial capital investments have enhanced advanced manufacturing capabilities and vertically integrated service offerings. U.S.-based contract development and manufacturing organizations (CDMOs) have received funding to expand their CNC machining, injection molding, additive manufacturing, and cleanroom packaging abilities. Private equity firms and OEMs have also engaged in strategic acquisitions and joint ventures to consolidate their strengths and achieve a competitive advantage in rapidly growing areas such as extremities and spine operations. These investments align with the increasing demand for speed, scalability, and regulatory adherence. The regulatory landscape in the U.S. is complex yet well-defined, with contract manufacturers required to adhere to the FDA's Part 820 (Quality System Regulation) and ISO standards. There has been heightened scrutiny regarding design traceability, sterilization validation, and supply chain risk management.
U.S. Orthopedic Contract Manufacturing Market Report Segmentation
This report forecasts revenue growth at country levels and analyzes the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. orthopedic contract manufacturing market report based on type, and service: